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Abstract
Posttranslational modifications (PTMs) of proteins play essential roles in regulating signaling,
protein-protein modifications and subcellular localization. In this review, we focus on
posttranslational modification of histones and RNA polymerase II (RNAPII) and their roles in gene
transcription. A survey of the basic features of PTMs is provided followed by a more detailed account
of how PTMs on histones and RNAPII regulate transcription in the model organism Saccharomyces
cerevisiae. We emphasize the interconnections between histone and RNAPII PTMs and speculate
upon the larger role PTMs have in regulating protein function in the cell.
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1. Introduction
1.1 Protein modifications in biology
With the completed sequencing of the human genome nearly a decade ago, it is now well
established that a relatively small number of genes (<30,000) give rise to a substantially larger
number of protein products (∼3×106–3×107) [1,2]. This great protein diversity is manifested
at the level of mRNA by alternative splicing or utilization of different transcription and
translation start and stop sites. Once the mRNA is translated into a protein product, further
protein diversification can be achieved by covalent modification of amino acid side chains,
hence the name “posttranslational modification” (PTM).
Protein modifications are very diverse in nature (totaling greater than 200) and can be found
on 15 of the 20 proteinogenic amino acids [3,4]. Some modifications are familiar (e.g.
phosphorylation) while others are found on only a few substrates (e.g. diphthamide) [5]. (For
a detailed examination of posttranslational modifications and associated mechanisms see [4]
and references therein). Regardless, many PTMs, and their associated biochemical pathways,
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are evolutionarily conserved between prokaryotes and eukaryotes, suggesting they play
indispensable roles in biology.
What are the functions of PTMs? Many modifications have evolved as a way of incorporating
more diverse functional groups into proteins such as phosphate or sulfate [4]. Others serve
varied biological roles, from controlling protein conformational stability [6] to controlling
localization of proteins within the cell [7]. Perhaps the most widely studied role of
modifications is their ability to mediate protein-protein interactions. A number of protein
domains have evolved to bind PTMs in specific protein contexts, such as SH3 and WW domains
that bind to proline-rich domains [8] or SH2 domains that recognize phosphotyrosine [9]. PTMs
also appear to play key roles in epigenetic processes as some of these modifications, such as
methylation on histones, can be maintained through cell divisions [10].
1.2. Scope of this review
Studies of PTMs are rooted in some of the earliest biochemical research [3,11-13]. While the
types of modifications and associated enzyme mechanisms are well established, in many cases
little is known about how these modifications function. This review will highlight some of the
modifications for which biological roles have been described and will try to put into a greater
context how diverse protein modifications modulate functions within the cell.
We will focus on two biologically connected processes, notably posttranslational modification
of histones and transcription by RNA polymerase II (RNAPII). We chose these processes not
only for their wonderfully diverse modifications but also because recent research has clearly
shown that the two processes are inextricably connected [14-17]. While there is an abundance
of literature on these topics, it is also evident that we have only scratched the surface of
understanding the full role of modifications in both these processes. Therefore, where
appropriate, we will attempt to speculate on what the future might hold for the role of PTMs
in these processes.
Since there have been several comprehensive reviews on histone modifications in higher
organisms in the recent literature [16,18,19], we will focus this review on histone PTMs in the
model organism Saccharomyces cerevisiae, as many of the modifications have been
extensively studied in this organism. Furthermore, yeast is an attractive model for studies of
PTMs as the number of proteins is comparatively small and several whole-proteome studies
of PTMs and protein-protein interactions in yeast have already been completed [20,21]. Much
of what we have learned in yeast has proven to be similar in higher organisms; therefore, many
of the processes we describe have parallels in mammalian cells as well.
We will review the historical links between histone modification and transcription and briefly
describe the common modifications found on RNAPII, focusing primarily on the modification-
rich C-terminal domain (CTD), and the core histones (comprehensive reviews of histone
modifications can be found elsewhere [18,22]). We will then put these modifications into
greater biological context highlighting several recent findings that demonstrate how
modifications of histones dictate changes in chromatin structure leading to changes in gene
expression. Additionally we will show how modification of RNAPII dictates changes to
histones modifications during transcription.
The goals of this review are twofold. One is to cover many of the major recent findings linking
histone modifications with transcription. The second is to convey the enormous role of non-
histone PTMs in modulating transcription and chromatin remodeling as well as their likely role
in many other biological processes.
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1.3. History of chromatin modifications and transcription
Histones have been known to associate with nucleic acids since their discovery in the 1880s
by Albrecht Kossel [23]. Their biochemical properties were heavily studied over the next half-
century and in 1951, Stedman and Stedman first hypothesized that histones could inhibit
nucleic acid-based processes including replication and RNA synthesis [24]. In much of the
early histone literature it was noted that they purified in multiple, closely related forms. These
forms were found to differ primarily by modifications on the histone side-chains including
phosphorylation, acetylation, and methylation. A biological role for histone modifications was
first proposed by Allfrey and Mirsky in 1964 when they observed that histone acetylation
correlated with increased rates of RNA synthesis [25,26].
Over the next thirty years, the functions of histone modifications would take a backseat to the
volumes of historic work detailing how genetic information is stored and copied. During this
time, the enzymes responsible for replication and transcription were extensively studied.
Further, the functional association between DNA and histones, the nucleosome, was reported
[27,28]. Understanding this genomic architecture would turn out to be essential to our
understanding of the role histone modifications play in regulating not only transcription but
other DNA-based processes.
In 1996, the connection between histone modifications and transcription again came to the
forefront. Allis and coworkers showed that a well-studied transcriptional activator, Gcn5, was
in fact an acetyltransferase enzyme that modified histones [29]. This provided biological
context to the observations of Allfrey and Mirsky of the 1960s. In similar work Schreiber and
coworkers linked transcriptional repression to deacetylase activity [30]. Thus the idea that
histone modifications could modulate gene expression was born. This idea was made manifest
a few years later with the “histone code” hypothesis [31-33].
The basic premise of the histone code hypothesis is that modifications on histone tails are
recognized by additional protein factors. In turn, these factors alter chromatin structure and
consequently, transcriptional output giving rise to complex patterns of gene expression. Some
modifications are stable between generations and presumably act as epigenetic marks as well.
The past ten years of research has resulted in the discovery of numerous modifications on
histones and the enzymes responsible for their deposition, many of which we will discuss here.
Further, many proteins and protein domains that recognize posttranslational modifications have
been described. Whether a true “histone code” exists is often a matter of debate, but the data
are clear – histones are modified to have complicated patterns of posttranslational marks along
their tails and these tails work both independently and in conjunction with one another to recruit
other factors to DNA. In the case of transcription, the situation is further complicated as
modifications on RNAPII can dictate which chromatin-modifying enzymes are able to gain
access to histones in a transcription-dependent manner.
2. Histone modifications associated with transcription
(Note: A new nomenclature for many of the histone-modifying enzymes has been recently
adopted. We will refer to proteins according to the new nomenclature [34] and have the more
established names in parenthesis to facilitate searching of the published literature).
2.1. The architecture of the nucleosome
The nucleosome is the basic unit of chromatin and is comprised of a protein core made up of
histone proteins (2 each of H2A, H2B, H3, and H4) around which approximately 146 base
pairs of double stranded DNA is wound. The histone proteins have a well-folded core domain
and unstructured tail domains on both the N- and C- termini [35]. While modifications occur
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within the core domains, the tail regions are rich with protein modifications as depicted in
Figure 1A. Modifications on the histone tails are thought to play important roles in controlling
chromatin architecture by modulating the stability of nucleosomal particles as well as
regulating what proteins are recruited to chromatin.
2.2. Acetylation and Deacetylation of Histones
Histone acetylation, the most prevalent modification on histones, is catalyzed by a number of
enzymes that transfer the acetyl moiety from Acetyl-CoA to the ε-amino group of lysine
residues. In yeast, there are 9 reported histone acetyltransferases (HATs) that act on the four
core histones. These HAT complexes have different substrate specificities, some recognizing
only a few sites while others acting on many lysine residues on multiple tails. HATs are
generally found as members of larger protein complexes, thus substrate specificity is most
likely regulated through associations with other complex subunits [36]. The intricacies of the
individual marks are beyond the scope of this discussion and are described in detail elsewhere
[37,38].
Histone acetylation is generally associated with transcription activation. Acetylation of lysine
alters the chemical properties of the amino acid converting the basic residue lysine into the
neutral charged ε-N-acetyllysine. In the context of chromatin, studies have shown that
acetylation can not only reduce the interaction of histones with DNA but also associations
between nucleosomes [39,40]. Consequently, acetylated nucleosomes are destabilized,
promoting both nucleosomal rearrangement by ATP-dependent chromatin remodeling
complexes and binding of a diverse set of DNA-binding factors involved in transcription, DNA
repair, and numerous other processes [41,42]. Often these remodeling factors are actually
recruited to chromatin through direct binding to the acetyl mark by bromodomains [43-46].
While histone acetylation generally promotes transcription, there is a competing process of
histone deacetylation that is generally thought to act in a repressive manner [47,48]. In yeast,
there are nine reported histone deacetylase enzymes (HDACs) belonging to one of two classes
[49]. Intuitively, HDAC function is generally associated with nucleosome stabilization and
repression of remodeling activities. It is, however, now clear that while HDACs act in
opposition to HATs, HDACs also function as activators of gene expression [50-52].
2.3. Histone methylation
Methylation is a considerably more complex modification than acetylation. Several amino
acids can be methylated including lysine and arginine on histones [4]. Up to three methyl groups
can be added to one lysine residue while arginine can accept up to two methyl groups, with
dimethylarginine being either symmetric or asymmetric [53]. Unlike acetylation, the charge
of the amino acid sidechain of lysine or arginine is unchanged by methylation. Similar to
acetylation, methylated residues serve as binding partners for a number of protein domains
including chromodomains [54] and PHD domains [55-57] which bind methyllysine, and Tudor
domains which can recognize both methyllysine and methylarginine [58-61].
Lysine methylation of histones in budding yeast has only been identified at a few locations:
histone H3 Lys4 (H3K4) [62], Lys36 (H3K36) [63] and Lys79 (H3K79) [64-66]. Fission yeast
and higher eukaryotes have several additional sites of methylation, including histone H3 Lys9
(H3K9) [67,68] and histone H4 Lys20 (H4K20) [69-71]. Lysine methylation differs from
acetylation in that it appears that methylation of different lysine residues is catalyzed by
different enzymes rather than one enzyme modifying multiple lysine targets. For example,
while Kmt2(Set1), Kmt3(Set2) and Kmt4(Dot1) modify histone H3 lysine residues at K4, K36
and K79 respectively, Gcn5(Kat2) is known to have a broad lysine substrate recognition on
histone H3 that includes lysine residues K9, K14, K18, K27 and K36 [72,73]. One reason some
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histone acetylases likely have such a broad substrate preference is that, in addition to recruiting
bromodomain-containing factors, acetylation changes the overall charge of the histone tails,
which in turn can regulate nucleosome-nucleosome and histone tail-DNA interactions that
drive chromatin decompaction. As lysine methylation has no inherent effect on histone charge,
the predominant role of lysine methylation is most likely in recruiting additional factors.
Histone methylation has many diverse roles in transcription. Methylation at H3K4, H3K36,
and H3K79, for example, is found associated with active transcription [74,75]. In contrast,
H3K9me in fission yeast, as well as H3K27me in higher eukaryotes, is associated with gene
silencing and heterochromatin formation [67,76,77]. Even though several sites of methylation
on H3 are all associated with active transcription, they have very different roles in regulating
transcriptional events. For example H3K4 methylation is known to promote transcription
elongation in higher eukaryotes and regulate RNA processing events [78,79]. H3K36
methylation, however, is associated with recruiting repressive deacetylase activites during
transcription elongation [80-82]. We will describe the roles of H3K36me in transcription in
greater detail later in this review. To date, the role of H3K79me in transcription is not well
understood although the mark can be found associated with promoters and coding regions of
most actively transcribed genes and is connected to the process of DNA repair [59,66,75,83,
84].
Arginine methylation is a modification most studied in RNA-binding proteins but also has been
reported on histone H4 at Arg3 (H4R3) and on histone H3 at Arg2 (H3R2) in yeast [85,86].
H4R3me is established by the predominant arginine methyltransferase in yeast, Hmt1. Silver
and colleagues have reported a role for H4R3 methylation in gene silencing [86]. Interestingly,
H3R2 methylation has also been associated with gene silencing, but through a mechanism that
involves antagonizing the establishment of H3K4 methylation at gene promoters [85].
Methylation was believed to be an irreversible mark for many years. Only recently have
demethylase enzymes been described that can act on both methyllysine and methylarginine
[87,88]. In yeast, it appears that like the methyltransferases, these enzymes have high
specificity and act on particular target residues and even on specific methylation states. For
example, the demethylase Kdm5(Jhd2) removes di- and trimethylation from H3K4 [89,90],
while H3K36me is removed by both Kdm2(Jhd1) and Kdm4(Rph1) [91,92]. While these
enzymes clearly act on histones, their roles in chromatin remodeling and transcription are
largely unexplored in yeast although much more is known in higher eukaryotes [88].
2.4. Phosphorylation
Phosphorylation of proteins is probably the most recognized protein modification; however,
phosphorylation is a relatively rare event on histones. Like in other processes, phosphorylation
of histones appears to correspond to changes in the extracellular environment. Phosphorylation
of Ser10 on H3 (H3S10) promotes transcription by influencing acetylation at H3K14 in
response to changes in carbon source [93]. Phosphorylation of H2B Ser10 (H2BS10) by Ste20
is a signal for apoptosis in response to oxidative stress [94-96]. A significant body of work has
been established that shows phosphorylation of the C-terminus of histone H2A is linked to
DNA damage repair [97]. Similarly, phosphorylation of histone H4 at Ser1 (H4S1) also
accompanies DNA damage [98]. While it is clear that H2A phosphorylation leads to
downstream changes in transcription, definitive links between this phosphorylation and the
transcription machinery have not been reported. H4S1 phosphorylation, however, has been
clearly shown to recruit the NuA4 HAT complex as well as the Swi/Snf chromatin remodeling
complex to genes resulting in histone acetylation and recruitment of RNAPII [99,100].
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Ubiquitin is a 76 amino acid protein that is attached to protein lysines through a complex system
of protein ligases [101]. These modifications have a variety of functions, including acting as
signaling marks, as mediators of protein-protein interaction, and in regulating protein stability.
In yeast, ubiquitin has to date only been found on one histone, histone H2B at Lys123 [102].
While the study of H2B ubiquitylation has been restricted to monoubiquitylation (H2Bub1),
very recently, polyubiquitylation of H2B has been reported [103]. In higher eukaryotes, H2A
is also ubiquitylated on Lys119 [104].
The role of ubiquitin in transcription is very complex. H2Bub1 is catalyzed by the Rad6/Bre1
ubiquitin-ligase complex and functions to promote transcriptional initiation and elongation
[102,105-107]. For example, H2Bub1 facilitates H3K4 methylation and works with the FACT
chromatin remodeling complex to promote transcription elongation (Figure 2) [108,109]. We
will further discuss the interplay between H2Bub1, H3K4 and RNAPII modifications later in
this review. Many roles of ubiquitination in transcription have recently been reviewed
elsewhere [110,111].
2.6. Sumoylation
In addition to ubiquitin, there are several other ubiquitin-like proteins that can be conjugated
to proteins in higher eukaryotes [112]. Yeast have two ubiquitin-like proteins, Smt3 and Rub1.
Smt3, SUMO (Small Ubiquitin-like Modifer) in higher eukaryotes, has been associated with
transcription. In fact, it has been reported that all four histones can be modified by SUMO
[113]. While the authors were unable to precisely define the locations of modification on H3,
sumoylation of H4 was found on at least 5 locations in the N-terminus H2B sumoylation is
thought to occur at Lys6/7 and Lys16/17. On H2A, SUMO is attached to Lys126.
The role of sumoylation in transcription is largely unknown. Berger and coworkers have shown
that sumoylation is in general a repressive mark, and in fact antagonizes histone acetylation
[113]. However, the exact mechanisms through which SUMO represses transcription are still
poorly understood.
2.7. Prolyl Isomerization
Proline isomerization is the only noncovalent posttranslational modification found to occur on
histones to date. The ring structure of the proline amino acid allows it to interconvert between
two conformations in proteins, either cis or trans. A change in proline conformation can
propagate a significant change in protein structure, some of which may serve functions within
the cell [114]. For example, the N-terminal tail of histone H3 has several prolines within its
sequence. Kouzarides and coworkers have shown that mutation of Pro38 affects the ability of
the Kmt3(Set2) enzyme to methylate the nearby H3K36 [115]. They also described the
corresponding enzyme, the prolyl isomerase Fpr4, which antagonizes H3K36 methylation by
Kmt3(Set2).
2.8. PMTs on Histone Variants
In addition to the canonical histones (H2A, H2B, H3, and H4), there also exist variants of these
histones that act in place of one of the four main histones and perform alternate functions. In
yeast, there are two, a variant of H2A called H2A.z (Htz1) and an H3 variant called Cse4 (also
known as CENP-A in metazoans). Cse4 is localized to centromeres in yeast [116,117] and
while it has been tied to chromatin remodeling complexes, no role for Cse4 in transcription
has been described [118,119]. Htz1 is found to replace H2A in the promoter regions of genes.
Htz1-containing nucleosomes are thought to be less stable than H2A-containing nucleosomes
and thus probably play some role in marking gene promoters. Htz1 is modified by the NuA4
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acetylase complex [120,121] and has also been reported to be a phospho-accepting substrate
of several kinases in vitro [20]. While Htz1 acetylation has been correlated with active
transcription, it is not known if Htz1 phosphorylation occurs in vivo and/or functions to regulate
nucleosome dynamics in transcription.
2.9. Other modifications
It is important to note that most of the histone modifications described above have been
identified in the last decade. It is likely that there are other modifications that have yet to be
identified. For example, the modifications described occur almost exclusively on the histone
tails. Modifications in the core regions are likely to occur and in fact several new sites of
acetylation in the core domains of H3 have been identified recently [122-124].
3. Modifications on Pol II associated with transcription
3.1. The C-terminal domain (CTD) of RNA Polymerase II
The largest subunit of the RNA Polymerase II (RNAPII) holoenzyme comprises not only the
catalytic core of RNAPII but also a very long, unstructured C-terminal region that is essential
for function. This C-terminal domain (CTD) is made up of multiple repeats (26 in yeast and
52 in humans) of a seven-amino acid consensus sequence YSTPSPS [125] (see Figure 1B).
The CTD acts as a scaffold making significant protein-protein interactions that link
transcription with PhosphoCTD-associated proteins (PCAPs) that are involved in many
biological processes including chromatin remodeling, cell cycle regulation, and mRNA
processing (see Figure 1B) [126]. These protein-protein interactions are dictated by a complex
set of post-translational modifications that occur on the CTD [125,127]. Here we will try to
summarize CTD modifications and their importance in transcription.
3.2. Ser2 and Ser5 Phosphorylation
Early analysis of the largest subunit of RNAPII (Rpb1) showed that the protein took on many
forms as judged by SDS-PAGE electrophoresis [128]. It was later determined that these
different gel mobilities signified varying levels of protein phosphorylation on the CTD,
specifically at Ser2 and Ser5 [129,130]. In yeast, Ser5 phosphorylation of RNAPII is catalyzed
by the cyclin-dependent kinase Kin28, which is part of the transcription complex TFIIH
[131-134]. There also exists supporting data that a factor of the Mediator complex, Srb10, also
phosphorylates Ser5, but only when RNAPII is not associated with a gene [135]. Thus
phosphorylation by Srb10 is though to prohibit pre-initiation complex (PIC) formation and
thus is a negative regulator of transcription.
Ser2 phosphorylation is catalyzed in vivo by the cyclin-dependent kinase Ctk1 [136].
Phosphorylation of Ser2 serves as a mark that denotes transcription elongation and requires
many factors, including Ser5 phosphorylation [125], removal of H2Bub1 [137], and association
of the PAF complex [138].
The phosphorylation state of RNAPII changes as the transcription machinery moves along a
gene. RNAPII bound at promoter regions is largely unphosphorylated [139]. Initiation of
transcription coincides with Ser5 phosphorylation by Kin28 [140]. During the elongation phase
of transcription, Ctk1 phosphorylates Ser2 to give a RNAPII that is modified at both Ser2 and
Ser5 [132]. As RNAPII travels along a gene, phosphorylation on the CTD is removed. The
phosphatase Ssu72 has been shown to remove Ser5 phosphorylation [141] while the
phosphatase Fcp1 is responsible for removing Ser2 phosphorylation [142]. It is thought that
dephosphorylation of the CTD is required for recycling of RNAPII on genes and may play a
role in gene looping [143-145].
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3.3. Prolyl isomerization by Ess1
As described earlier, prolyl isomerases catalyze the interconversion of the two conformations
of proline residues. As is evident from the protein sequence of the RNAPII CTD, there are two
prolines in every repeat. Hanes and coworkers found that the prolyl isomerase Ess1 is essential
for growth in yeast and binds to the RNAPII CTD [146]. While its activity has never been
observed in vivo, modification of the catalytic residues of Ess1 results in a temperature-
sensitive phenotype suggesting that at least one function of Ess1 may be to act on the CTD.
3.4. Ubiquitination
As described for H2B, ubiquitylation is a common modification of lysine residues.
Monoubiquitylation often serves as a protein-protein interaction mark while polyubiquitylation
usually signals for degradation. The largest subunit of RNAPII, Rpb1, associates with members
of the ubiquitin-ligase machinery as well as the proteasome (responsible for degrading
polyubiquitylated substrates) [147,148]. WW domains within Rsp5 mediate binding to the
elongating RNAPII CTD and Rsp5 then ubiquitylates distant sites on Rpb1 in conjunction with
an E2 protein Ubc5, targeting Rpb1 for degradation in response to DNA damage [149]. This
process is further regulated by other RNAPII subunits including the nonessential subunit Rpb9
[150]. A recent result from Svejstrup and colleagues shows that deubiquitylation of Rpb1 is
also a crucial process, as loss of the ubiquitin protease Ubp3 facilitates removal of stalled
RNAPII complexes in response to DNA damage [151].
3.5. Other modifications
The richness of modifications on the CTD leaves one asking whether there are still
undiscovered modifications. In fact, late last year, two groups reported that Ser7 of the CTD
could be phosphorylated in mammalian cells [152,153]. Also, there are reports of glycosylation
of both Ser2 and Ser5 in higher eukaryotes as well [154,155]. Tyrosine residues can also be
modified in several ways including phosphorylation, sulfation and nitrosylation [4]. The
existence of these modifications in yeast has not been reported but clearly these modifications
are possible in this organism. Thus, the future will reveal whether these additional
modifications are conserved and play important roles in regulating transcription-associated
processes or whether we have found evolutionary differences in CTD modifications between
yeast and metazoans.
We have chosen to restrict our discussion to modifications on the CTD of the largest subunit
of RNA polymerase. However, there are eleven other subunits associated with the RNA
polymerase holoenzyme in addition to Rpb1. Several of the other subunits have been reported
to be substrates of casein kinase II (CKII) indicating that multiple members of the RNAPII
holoenzyme are likely to be modified [156]. Future work will likely be aimed at understanding
what role PTMs of the RNAPII holoenzyme play in regulating transcription. While the answers
are still unknown, it is likely that these modifications are important signals coordinating
transcription with other cellular processes.
4. The Interplay between histone modifications and RNA polymerase
Hundreds of proteins are needed to properly carry out the process of transcription. Hundreds
more are required to properly integrate transcription with other processes such as cell cycle
progression, cellular metabolism, and RNA processing [157]. As we have already described,
transcription is also tightly coupled to changes in chromatin architecture. While researchers
have determined most of the chromatin and RNAPII modifications associated with
transcription, the mechanisms through which these modifications modulate gene expression
have only begun to be elucidated. In this section, we will highlight a few stories for which we
have considerable information about how protein modifications and histone modifying
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enzymes interplay with RNAPII to dictate patterns of gene expression. These examples will
serve to emphasize one essential role that protein modifications play in cell physiology.
4.1. H3K4 methylation, H2B ubiquitination and CTD phosphorylation
H3K4 methylation in yeast is catalyzed by the enzyme Kmt2(Set1), which is part of a larger
protein complex called COMPASS [62,138,158]. It is well established that the presence of
H3K4 methylation correlates with nucleosomes residing within genes that are being actively
transcribed. As mentioned earlier, lysines can have one (me1), two (me2) or three (me3) methyl
groups attached to them. H3K4me3 is most prevalent near promoter regions and then H3K4me2
and H3K4me1 become more abundant in the coding regions of genes [75]. Several questions
arise from these findings. For example, do these different methylation states have different
functions, and what factors are required for establishing different methyl states?
As we described earlier, it appears that many protein domains are able to recognize
methyllysine. Though not confirmed, it is also likely that these binding domains can also
distinguish between different methyl states (i.e. me1, me2, me3). Several different proteins
have been described that bind to H3K4me both in yeast and humans [57,159-162]. These
proteins have diverse functions including controlling the extent of nucleosome remodeling,
demethylation, acetylation, and PIC formation. Therefore, it appears that the different methyl
states on H3K4 dictate what factors interact with chromatin. In fact, H3K4 seems to be so
important for regulating interactions of binding proteins with nucleosomes that a motif has
been recently reported that recognizes unmodified H3K4 in mammalian cells [163].
There are numerous signals that control the methylation of H3K4. H3K4me requires careful
coordination of protein modifications not only on histones (i.e. H2Bub) but also RNAPII, as
well as recruitment of other transcription factors. COMPASS recruitment to the CTD requires
phopshorylation at Ser5, catalyzed by the TFIIH member, Kin28. Kmt2(Set1) does not appear
to directly interact with the CTD tail, rather COMPASS appears to be recruited to the CTD
through interactions with the PAF transcriptional complex, which is known to directly interact
with RNAPII [138]. In addition to CTD phopshorylation, Kmt2(Set1) also requires
ubiquitylation of H2B (H2Bub1) for proper methylation of substrates [164-166]. This finding
was some of the earliest support for the idea of the “histone code” because it showed that protein
modifications on one histone tail directly influenced enzymatic modification of a different tail
[167]. This concept has become known as a “trans-tail pathway” and since several other similar
mechanisms have been described [168].
Recently, Shilatifard and coworkers uncovered the basis for H2Bub1 regulation of H3K4me
[169]. They demonstrated that in the absence of H2Bub1, the Cps35 subunit of COMPASS
does not associate with the rest of the complex and thus the complex is not catalytically
competent. This outlines a biological role for Cps35, the only essential subunit of COMPASS.
According to their model, H2B ubiquitylation directs H3K4 methylation by stabilizing the
interaction between Cps35 and the rest of COMPASS, thus making the complex catalytically
competent. This finding is significant in that it biochemically defines the factors that “translate”
the “trans-tail” pathway. However, these results stimulate many additional questions regarding
the role of Cps35 in regulating these processes. For example, as mentioned earlier, Cps35 is
the only essential member of COMPASS. It also happens to be a member of the cleavage and
polyadenylation factor complex (CPF). Is the essential role for Cps35 in coordinating the
activity of COMPASS, in mRNA processing, or perhaps in linking these two processes
together? There is likely to be an exciting future in unraveling the many functions of Cps35.
This story demonstrates how numerous modifications on several proteins (including histones
and RNAPII) regulate a histone mark that has an important role in gene expression. Even with
the considerable knowledge we have concerning the function of H3K4me, there are many
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questions still largely unanswered. For example, while H3K4me correlates with the promoter
and early coding regions of many genes, it is not required for viability. What then is the actual
role of H3K4me in transcription? Reinberg and coworkers have uncovered a role for H3K4me
in RNA processing [79]. Does something analogous to this occur in yeast?
4.2. Kmt3(Set2) and CTD phosphorylation
The methyltransferase Kmt3(Set2) was described a few years ago as an enzyme responsible
for methylating Lys36 of histone H3 (H3K36) [63,170]. Investigators determined that Kmt3
(Set2) methylation of H3K36 was occurring cotranscriptionally and that Kmt3(Set2) associated
directly with RNAPII. In a number of structural and biochemical studies, a unique domain of
Kmt3(Set2) was described that bound specifically to the CTD of Rpb1 [171]. In collaboration
with the Greenleaf laboratory, we showed that Kmt3(Set2) associates preferentially with the
CTD phosphorylated at both Ser2 and Ser5 [171]. Deletion of the Ctk1 kinase responsible for
Ser2 phosphorylation resulted in a loss of H3K36 methylation, suggesting that binding of Kmt3
(Set2) to the CTD is essential for its activity in vivo [172,173]. Subsequent work determined
that H3K36me is most prominently associated with nucleosomes positioned in the mid- to late
coding region of actively transcribed genes, consistent with Kmt3(Set2) association to the
actively elongating form of RNAPII [75,172-174].
Like H3K4me, H3K36me is recognized by methyllysine-binding proteins. The Buratowski,
Struhl and Workman labs showed that the chromodomain of Eaf3 bound specifically to
H3K36me [80-82]. Eaf3 is a component of both the NuA4 HAT complex and the small Rpd3
deacetylase complex known as Rpd3S [81,82]. It was determined that Rpd3S was the Eaf3-
containing complex that interacts with H3K36me, which also depends on an additional histone
interactions mediated by a PHD finger in the only Rpd3S-specific factor RcoI [175]. It was
also clearly shown that methylation of H3K36 was capable of recruiting Rpd3 to chromatin,
which in turn, resulted in deacetylation of nucleosomes [81,82]. More recently, the Strahl and
Mellor labs have reported that H3K36me2 is sufficient to recruit deacetylase activity to genes
[176]. Thus methylation of H3K36me2 plays a repressive role in transcriptional processes by
recruiting enzymes to remove acetylation from nucleosomes. Whether H3K36me3, which is
preferentially associated with actively transcribing genes, plays a distinct role in gene
transcription through the recruitment of a second H3K36me-binding protein is unknown but
remains an intriguing possibility.
The biological relevance of maintaining the coding regions of RNAPII-regulated genes in a
deactylated state was demonstrated by showing that when Kmt3(Set2) or several members of
the Rpd3S complex were deleted, nucleosomes in actively transcribed regions were
hyperacetylated and cryptic start-sites within genes were inappropriately utilized [82]. These
results demonstrate how precise modifications on histone tails can create changes in chromatin
that function to direct transcriptional initiation events to the appropriate places within the
genome.
This work, highlighting Kmt3(Set2) and H3K36 methylation, shows how modifications on the
CTD recruit chromatin-modifying activities, which in turn dictate the expression patterns of
certain genes. Thus there exists a complicated regulatory mechanism where at least four
different modifications (phosphorylation, methylation, ubiquitylation and acetylation/
deacetylation) determine how a given gene is expressed. This mechanism will only become
more complex as we learn more about the upstream signals that dictate CTD phosphorylation
patterns. For example, our lab has recently found that binding to RNAPII regulates the stability
of Kmt3(Set2) protein in a proteasome-specific manner (Fuchs, S.M. and Strahl, B.D.,
unpublished data). Thus there appear to be additional mechanisms to tightly control Kmt3
(Set2) activity in response to changes in CTD phosphorylation.
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4.3. H3K14, SAGA and RSC - Chromatin remodeling and gene expression
The first two stories highlighted focus on the factors that regulate methylation of different sites
on histone H3. Complex posttranslational regulation extends far beyond histone methylation.
As an example, we will highlight some work focusing on how other PTMs, specifically
acetylation and phosphorylation coordinate regulation of gene expression.
Kat2(Gcn5), the catalytic subunit of the SAGA histone acetyltranfserase complex, is
responsible for acetylation of a number of lysine residues on both histones H3 and H4 [37].
One of these marks, acetylation at lys14 of histone H3 (H3K14ac) has received considerable
interest due to its role in recruiting the RSC chromatin remodeling complex [177]. In addition
to modifying histones, Kat2(Gcn5) is also known to acetylate non-histone proteins. In the case
of RSC, in particular, non-histone acetylation turns out to play a crucial role in gene expression
as well. In this section we will describe some of the modifications that contribute to chromatin
remodeling by RSC.
As previously stated, histone acetylation is an important factor in loosening chromatin structure
that acts to promote transcription. H3K14 is only one of a number of residues that is acetylated
by SAGA. Interestingly, SAGA can be specifically recruited to H3K14 by signals elsewhere
on the H3 tail. Specifically, phosphorylation of Ser10 on histone H3 (H3S10P) has been shown
to increase H3K14ac on certain genes leading to changes in gene expression [178]. H3S10 is
phosphorylated by the kinase Snf1 in yeast in response to carbon source to upregulate
expression of genes involved in metabolism [93].
How does acetylation at H3K14 cause changes in transcription? At least one answer is by
recruiting the additional chromatin remodeling activities of the RSC complex [179]. RSC is a
very abundant ATP-dependent chromatin remodeling complex in yeast that plays important
roles in regulating gene expression during a number of processes [118,180]. RSC functions to
stimulate transcription elongation by remodeling nucleosomes and recruiting HAT activities
[181]. RSC contains at least 15 protein subunits several of which contain domains
(bromodomains and BAH domains) that interact with acetylated lysine residues and other
unmodified residues within histones. In particular, Cairns and coworkers have shown that
tandem bromodomains of Rsc4, an essential member of the RSC complex, specifically interact
with H3K14ac [177]. RSC is also known to travel with RNAPII, but unlike Kmt3(Set2), it does
not appear to associate with the CTD. Instead, the Rsc4 subunit of RSC interacts with the Rbp5
subunit of RNAPII holoenzyme and that this interaction is critical to RSC function [182]. Thus
RSC appears to play an important role in remodeling nucleosomes at sites of H3K14ac.
Regulation of RSC function by Kat2(Gcn5) goes beyond its ability to acetylate H3K14. As a
consequence of solving the crystal structure of Rsc4, Cairns and coworkers noted the presence
of an acetylated lysine (Lys25) within Rsc4 itself [183]. Acetylation of Rsc4 by Kat2(Gcn5)
was found to inhibit Rsc4 binding to H3K14ac. Thus it is appears as if Kat2(Gcn5) acts to both
stimulate and inhibit remodeling by RSC. This also appears to be similar to the role of H3S10P
as phosphorylation recruits Kat2(Gcn5) yet seems to impede Rsc4 binding. It is therefore likely
that H3S10P is a transient mark and an unknown phosphatase removes this mark following
H3K14 acetylation to allow Rsc4 recruitment (see Figure 4).
The finding that Rsc4 is acetylated and that acetylation regulates its own function raises many
further questions about how protein modifications regulate transcription. Are other
transcription factors, or regulators of transcription, modified by what are traditionally thought
of as “histone-modifying enzymes”? If so, how do these modifications regulate their function?
For example, in higher eukaryotes it is now well established that steroid hormone receptors
are highly regulated by phosphorylation [184]. The oncogene p53 is known to be
phosphorylated as well as methylated, acetylated, sumoylated and ubiquitinated [185].
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Therefore, it is clear that the role PTMs extends far beyond modification of just histones and
RNAPII.
5. Concluding Remarks
We began by noting that proteomics predictions estimate that there are considerably more
proteins in a cell than what are encoded by the DNA. In this review we touched on a number
of modifications known to be important for regulating chromatin structure and transcription.
However, we limited our discussion to just a handful of modifications on only a few proteins.
With the rapid evolution of high-throughput proteomics techniques, our understanding of the
extent of protein modification will undoubtedly increase in the next few years. Deciphering
the roles of newfound modifications will become more complex as the number of modified
proteins increases. Perhaps, understanding the complex networks of protein modifications is
the key to understanding how transcription integrates with other cell processes such as mRNA
processing, cell-cycle regulation, and signaling events.
Histone tails seem to be the richest sources of protein modifications in cells. This is likely due
to their essential roles in maintaining chromatin structure. Are there other modification-rich
proteins that have been largely overlooked? Preliminary evidence suggests there are. RNA-
binding proteins as well as ribosomal proteins are known to be heavily methylated [186]. What
are the roles of methylation in mRNA processing or translation? Structural proteins such as
myelin basic protein are decorated with a diverse set of modifications that seem to play essential
roles in neurodegenerative disorders [187]. How do modifications of these proteins regulate
protein function? Perhaps the most complex modifications are manifest outside the cell.
Researchers have spent decades studying how glycosylation patterns on proteins dictate how
a cell interacts with its environment [188]. Deciphering glycosylation is key to understanding
a number of today's biomedical problems including cancer metastasis and cell differentiation
[189].
Protein modifications will likely continue to play a starring role in future stories of chromatin
structure and gene regulation. As more modifications are identified, it is likely that these PTMs
will be key players in the regulation of gene expression as well as other biological processes
in the cell. In that respect, previous and current work on histone modifications will serve as a
roadmap for deciphering the function of protein modifications in biology.
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Posttranslational modifications (PTMs) found on histones and RNA polymerase II (RNAPII).
(A) Most common PTMs found on the N- and C-terminal tails of the four canonical histones
in yeast. (B) Sites of phosphorylation within the 26-repeat C-terminal domain (CTD) of Rpb1,
the largest subunit of RNAPII. Phosphorylation of Ser5 is primarily catalyzed by Kin28 and
removed by Ssu72. Phosphorylation of Ser2 is primarily catalyzed by Ctk1 and removed by
Fcp1. Ess1 is thought to facilitate prolyl isomerization within the CTD. Differential
phosphorylation of the CTD leads to recruitment of distinct phosphor-CTD associating proteins
(PCAPs) in a spatially and temporally controlled manner to regulate specific transcription-
associated processes (e.g. chromatin remodeling and mRNA processing).
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H3K4 methylation and transcriptional activation. The COMPASS methyltransferase is
recruited to the promoter regions of genes through interactions with the PAF complex and
serine 5 phosphorylation, as well as by making contacts with H2Bub1 through Cps35 (See
text). Recruitment of COMPASS leads to the restricted establishment of H3K4me3 near the
transcriptional start site This modification may serve to stabilize PIC formation and recruit
chromatin remodeling and histone modifying activities that facilitate the transcription process
(see text for details). Also associated with COMPASS and the elongating RNAPII complex is
the histone chaperone complex, FACT, which disassembles and reassembles nucleosomes to
promote transcription. FACT function and COMPASS activity are both functionally regulated,
at least in part, through H2Bub1 [110].
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Role of H3K36 methylation in transcriptional dampening. Following CTD phosphorylation by
Ctk1, the Kmt3(Set2) methyltransferase is recruited to the elongating form of RNAPII via its
SRI domain [171]. Kmt3(Set2) methylates H3K36, leading to Rpd3(S) deacetylase recruitment
and deacetylation of ORF specific nucleosomes. This event regulates the removal of
elongation-linked acetylation and thereby prevents inappropriate initiation events from
occurring in gene bodies. Thus, H3K36me serves to maintain proper transcription initiation at
the promoter regions of genes.
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Acetylation both stimulates and inhibits RSC chromatin remodeling activities. Kat2(Gcn5) is
recruited to acetylate H3K14 by Snf1-mediated phosphorylation of H3S10. During
transcription, RSC chromatin remodeling activities is recruited via Rsc4 which binds to
H3K14ac via its tandem bromodomains and with RNAPII through interactions with Rpb5.
Rsc4 can also be directly acetylated by Kat2(Gcn5) leading to inactivation of the complex.
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